Dr. Giullian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 16th St
Denver, CO 80202Phone+1 615-294-8534
Summary
- Dr. Jeffrey Giullian is the Chief Medical Officer at DaVita, a dialysis and holistic kidney care organization. He received his medical degree from Vanderbilt University School of Medicine and MBA from the University of Colorado at Denver. Prior to joining DaVita in 2016, Dr. Giullian practiced general and transplant nephrology and served in several hospital and national organization leadership positions.
Education & Training
- Vanderbilt University Medical CenterFellowship, Nephrology, 2005 - 2008
- Baylor College of MedicineResidency, Internal Medicine, 2001 - 2005
- Vanderbilt University School of MedicineClass of 2001
Certifications & Licensure
- WA State Medical License 2019 - 2026
- CO State Medical License 2019 - 2025
- OR State Medical License 2019 - 2025
- PA State Medical License 2018 - 2024
- TN State Medical License 2019 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 7 citationsLifesaving Care for Patients with Kidney Failure during the War in Ukraine 2022.Natalia Stepanova, Mykola Kolesnyk, Zain Mithani, Baneen Alkofair, Rebecca Lauren Shakour
Clinical Journal of the American Society of Nephrology. 2022-07-01 - 15 citationsComparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients.Steven M Brunelli, Scott Sibbel, Steph Karpinski, Gilbert Marlowe, Adam G Walker
Journal of the American Society of Nephrology. 2022-04-01 - 2 citationsA Hospital-Based Program to Reduce Central Line-Associated Bloodstream Infections among Hospitalized Patients Receiving Hemodialysis Using a Central Venous Catheter fo...Patricia Conwell, Michael Aniskiewicz, Jennifer Ghidini, Laura DeVaux, Mark A. Perazella
Nephrology Nursing Journal. 2019-05-01
Press Mentions
- Dialysis Centers: Give Us a Chance at COVID VaccinationFebruary 1st, 2021
- Dialysis Path Leads to Improvements in Health EquityJanuary 19th, 2021
- COVID-19 Crisis Could Speed Adoption of Home DialysisApril 24th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: